The Weekly Scale: March 1st 2021

This week at MarketScale, we locked in the hottest roundtables, praised our AI overlords, and I asked myself who is the Steve Jobs of B2B.

Close the door of the fireplace, it’s the start of a new week and it’s time to scale up.

Can data revolutionize how homeowners manage and maintain their property?

This week on Dirt Work, host Adam Morrisey sat down with a start up out of Austin texas that is aiming to use AI & IoT to make the home less expensive and demanding to own.

As we exit the era of the pandemic, we are at a philosophical cross roads on the future of workspaces.

This week on Digital Directions, Radiant Technology Group’s Doug Freutel discusses trends for leveraging digital signage to create future flexible workspaces in this first of a two-part discussion.

Every industry the world over is feeling the effects of innovative IoT solutions, and the restaurant and hospitality sectors are certainly no exception.

Intel’s Orietta Verdugo joins To the Edge and Beyond to outline how intel is committing to elevate and personalize the guest experience in the restaurant and hospitality landscape, from drive-thrus to five-star overnight stays.

Today more than ever, Merchants need a partner they can rely on.

FreedomPay is hosting Next Level Commerce, a virtual event looking at the American payment revolution and the changing behavior of the consumer at the point of sale. Be sure to join this Thursday at 1030am CT.

Stop. Drop. and Shop. On the next MarketScale Roundtable we are bringing together some of the sharpest minds in ecommerce and brick & mortar to explore the retail rebound and the future of work

The panel will include:

Melissa Gonzalez, Retail Refined & Lionesque Group, Jack Hogan of Mashgin, Peter Ikeler, from SUNY Old Westbury, and April Sabral of retailu

Make sure to follow along for future roundtables. We are serving up a side of fries for our QSR round table on March 8th

I’ll be back next Monday for The Weekly Scale but, until then, if you know of a story that you want us to cover, let us know with the hashtag B2BNeverSleeps.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More